Publications and Presentations Database
]
(2018). A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone..
Genetics in medicine : official journal of the American College of Medical Genetics. 20(1), 132-41. Abstract
(2016). Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial..
Annals of internal medicine. 164(3), 155-63. Abstract
(2014). A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease..
Alzheimer's & dementia. Abstract
(2009). Disclosure of APOE genotype for risk of Alzheimer's disease.
The New England journal of medicine. 361(3), 245-54. Abstract
(2009). Disclosure of APOE genotype for risk of Alzheimer's disease.
The New England journal of medicine. 361(3), 245-54. Abstract
(2008). Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.
Genetics in medicine : official journal of the American College of Medical Genetics. 10(3), 207-14. Abstract
(2006). Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.
Genetics in medicine : official journal of the American College of Medical Genetics. 8(12), 746-51. Abstract
(2005). Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
Journal of geriatric psychiatry and neurology. 18(4), 250-5. Abstract
(2004). Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.
Genetics in medicine : official journal of the American College of Medical Genetics. 6(4), 197-203. Abstract
(2003). Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.
Alzheimer disease and associated disorders. 17(2), 86-93. Abstract
